Table 1.
Trend of Available Liver Tests Related to Nonsteroidal SARM Use for Case 1
| Case 1 | |||||
|---|---|---|---|---|---|
| Timeline | ALT, U/L (<40) | AST, U/L (<40) | ALP, U/L (30‐110) | Bilirubin, μmol/L (2‐20) | Comment |
| Baseline | 29 | — | 111 | 4 | 4 years prior |
| −6 weeks | SARM use ceased after 9 weeks of use | ||||
| −2 weeks | 589 | 175 | 197 | 68 | Symptoms present for 3 weeks when seen by primary care physician |
| −1 week | 273 | 111 | 289 | 116 | Referred to hepatologist |
| Initial review by hepatologist | 160 | 76 | 272 | 92 | |
| 2 weeks | 334 | 155 | 266 | 46 | |
| 4 weeks | 178 | — | 182 | 23 | |
| 8 weeks | 79 | — | 134 | 18 | |
| 8 months | 20 | — | 96 | 13 | |